SCHEMBL4164026

SCHEMBL4164026

CC(=O)c1cccc(NC(=O)[C@H](CCCSCC(=O)C(F)(F)F)NC(=O)CS(C)(=O)=O)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.54
TSHR P16473 3/20 0.54
NPC1 O15118 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
RAB9A P51151 1/20 0.39
KMT2A Q03164 5/20 0.38
MAPT P10636 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
POLB P06746 1/20 0.37
PLAU P00749 1/20 0.37
HPN P05981 1/20 0.37
LMNA P02545 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
HDAC4 P56524 2/20 0.37
MEF2D Q14814 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4174395 0.88 ALDH1A1 (0.48) ALDH1A1TSHRNPC1CYP1A2CYP3A4
SCHEMBL3507991 0.86 ALDH1A1 (0.45) ALDH1A1TSHRNPC1CYP1A2CYP3A4
SCHEMBL4160412 0.84 HTT (0.46) ALDH1A1TSHRNPC1CYP1A2CYP3A4
SCHEMBL4166185 0.82 NPC1 (0.42) ALDH1A1TSHRNPC1CYP1A2CYP3A4
SCHEMBL4158976 0.82 HDAC4 (0.53) ALDH1A1TSHRKMT2AHDAC4MEF2D
SCHEMBL4165005 0.80 ALDH1A1 (0.41) ALDH1A1TSHRNPC1RAB9AKMT2A
SCHEMBL4162559 0.80 ALDH1A1 (0.41) ALDH1A1TSHRNPC1RAB9AKMT2A
SCHEMBL4156189 0.79 CYP1A2 (0.48) ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL4152045 0.79 ALDH1A1 (0.41) ALDH1A1TSHRNPC1CYP1A2CYP3A4
SCHEMBL5125020 0.77 ALDH1A1 (0.59) ALDH1A1TSHRKMT2ASMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054448-A1 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors JONES PHILIP 2009-02-26 US disclosed
EP-1945609-A2 AMINO ACID DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) 2008-07-23 EP disclosed
WO-2007029036-A2 AMINO ACID DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2007-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054448-A1 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors HDAC5, HDAC1, HDAC11 ALDH1A1 320/4885TSHR 1377/4885NPC1 1625/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.